[an error occurred while processing this directive]
|
Risedronate sodium
Risedronate sodium (brand name Actonel) is approved for the prevention and treatment of osteoporosis in post-menopausal women and for the prevention and treatment of glucocorticoid-induced osteoporosis in both men and women. Risedronate, a bisphosphonate, has been shown to slow or stop bone loss, increase bone mineral density, and reduce the risk of spine and nonspine fractures. It is taken in pill form once a week.
|  |
|
In clinical trials, side effects of risedronate were minimal to moderate and those that were reported occurred equally among people taking the medication and those taking a placebo. Risedronate should be taken with a glass of water at least 30 minutes before the first food or beverage of the day other than water. After taking risedronate, it is important to remain in an upright position and refrain from eating for at least 30 minutes.
|
